Board Meeting Intimation for The Quarter Ended June 302026
04-Aug-2026 | Source : BSELasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.
Closure of Trading Window
29-Jun-2026 | Source : BSEClosure of trading window for the quarter ended June 30 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEAnnual Secretarial Compliance Report as on March 31st 2026
Corporate Actions
14 Aug 2026
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available